×
About 55,414 results

ALLMedicine Psoriasis Center

Research & Reviews  23,305 results

A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.
https://doi.org/10.1097/MD.0000000000020048
Medicine Charakopoulos E, Spyrou I et. al.

Jun 1st, 2020 - Ustekinumab is a biological agent that inhibits interleukin 12 and 23 and has been approved for the treatment of moderate and severe plaque psoriasis. There have been case reports that raise concerns about its oncogenic potential. We are the first...

Safety and efficacy of Chinese herbal bath for psoriasis vulgaris: A protocol for syste...
https://doi.org/10.1097/MD.0000000000020488
Medicine Lin W, Yu Q et. al.

Jun 1st, 2020 - Psoriasis is a common, chronic, and recurrent skin inflammatory disease, with psoriasis vulgaris considered as the most prevalent type of psoriasis. Chinese herbal bath, a type of traditional Chinese medicine, is an external therapy widely used to...

Cost per responder for guselkumab versus secukinumab in the United States based on a he...
https://doi.org/10.1080/09546634.2020.1770172
The Journal of Dermatological Treatment; Teeple A, Fitzgerald T

Jun 1st, 2020 - Aims: To estimate cost per response (CPR) in the United States and number-needed-to-treat (NNT) among subjects receiving guselkumab or secukinumab for moderate to severe plaque psoriasis.Materials and methods: Results from ECLIPSE, a double-blind,...

Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from ...
https://doi.org/10.1111/bjd.19262
The British Journal of Dermatology; Reich K, Sullivan J et. al.

Jun 1st, 2020 - Secukinumab, a fully human monoclonal antibody that selectively neutralises interleukin-17A, a cornerstone cytokine in psoriasis, has shown long-lasting efficacy and safety in the complete spectrum of psoriasis manifestations. To report the long-t...

The importance of immunity in the development of reliable animal models for psoriasis a...
https://doi.org/10.1111/imcb.12365
Immunology and Cell Biology; Guerrero-Aspizua S, Carretero M et. al.

Jun 1st, 2020 - Psoriasis (PS) and atopic dermatitis (AD) are common inflammatory skin diseases characterized by an imbalance in specific T cell subsets, resulting in a specific cytokine profile in patients. Obtaining models closely resembling both pathologies is...

see more →

Guidelines  151 results

Genital Ulcers: Differential Diagnosis and Management
https://www.aafp.org/afp/2020/0315/p355.html
American Family Physician; Roett MA,et al

Mar 14th, 2020 - Genital ulcers may be located on the vagina, penis, and anorectal or perineal areas and may be infectious or noninfectious. Herpes simplex virus is the most common cause of genital ulcers in the United States. A diagnosis of genital herpes simplex...

Genital Ulcers: What Causes Them?
https://www.aafp.org/afp/2020/0315/p355-s1.html
American Family Physician;

Mar 14th, 2020 - They are usually caused by sexually transmitted infections (STIs), most commonly herpes, less commonly syphilis, and rarely chancroid (SHAN-kroid). For men who have sex with men, syphilis is the most common cause. Rare cases of mononucleosis (MAA-...

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care ...
https://doi.org/10.1016/j.jaad.2020.02.044
Journal of the American Academy of Dermatology; Menter A, Gelfand JM et. al.

Mar 2nd, 2020 - Psoriasis is a chronic inflammatory disease involving multiple organ systems and affecting approximately 2% of the world's population. In this guideline, we focus the discussion on systemic, nonbiologic medications for the treatment of this diseas...

Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review
https://www.mdpi.com/1422-0067/21/5/1690/htm
International Journal of Molecular Sciences; Kamata M,et al

Feb 29th, 2020 - Psoriasis is a chronic inflammatory skin disease characterized by scaly indurated erythema. It impairs patients’ quality of life enormously. It has been recognized not only as a skin disease but as a systemic disease, since it also causes arthriti...

Pathogenesis of Chronic Plaque Psoriasis and Its Intersection With Cardio-Metabolic Comorbidities
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7052356/
Frontiers in Pharmacology; Gisondi P,et al

Feb 24th, 2020 - Psoriasis is a chronic, systemic immune-mediated disease characterized by development of erythematous, indurated, scaly, pruritic plaques on the skin. Psoriasis is frequently associated to comorbidities, including psoriatic arthritis, cardiovascul...

see more →

Drugs  1,155 results see all →

Clinicaltrials.gov  26,451 results

A case report of Hodgkin lymphoma in a patient treated with ustekinumab for psoriasis.
https://doi.org/10.1097/MD.0000000000020048
Medicine Charakopoulos E, Spyrou I et. al.

Jun 1st, 2020 - Ustekinumab is a biological agent that inhibits interleukin 12 and 23 and has been approved for the treatment of moderate and severe plaque psoriasis. There have been case reports that raise concerns about its oncogenic potential. We are the first...

Safety and efficacy of Chinese herbal bath for psoriasis vulgaris: A protocol for syste...
https://doi.org/10.1097/MD.0000000000020488
Medicine Lin W, Yu Q et. al.

Jun 1st, 2020 - Psoriasis is a common, chronic, and recurrent skin inflammatory disease, with psoriasis vulgaris considered as the most prevalent type of psoriasis. Chinese herbal bath, a type of traditional Chinese medicine, is an external therapy widely used to...

Cost per responder for guselkumab versus secukinumab in the United States based on a he...
https://doi.org/10.1080/09546634.2020.1770172
The Journal of Dermatological Treatment; Teeple A, Fitzgerald T

Jun 1st, 2020 - Aims: To estimate cost per response (CPR) in the United States and number-needed-to-treat (NNT) among subjects receiving guselkumab or secukinumab for moderate to severe plaque psoriasis.Materials and methods: Results from ECLIPSE, a double-blind,...

Secukinumab shows high and sustained efficacy in nail psoriasis: 2.5-year results from ...
https://doi.org/10.1111/bjd.19262
The British Journal of Dermatology; Reich K, Sullivan J et. al.

Jun 1st, 2020 - Secukinumab, a fully human monoclonal antibody that selectively neutralises interleukin-17A, a cornerstone cytokine in psoriasis, has shown long-lasting efficacy and safety in the complete spectrum of psoriasis manifestations. To report the long-t...

The importance of immunity in the development of reliable animal models for psoriasis a...
https://doi.org/10.1111/imcb.12365
Immunology and Cell Biology; Guerrero-Aspizua S, Carretero M et. al.

Jun 1st, 2020 - Psoriasis (PS) and atopic dermatitis (AD) are common inflammatory skin diseases characterized by an imbalance in specific T cell subsets, resulting in a specific cytokine profile in patients. Obtaining models closely resembling both pathologies is...

see more →

News  4,139 results

FDA Approves Ixekizumab (Taltz) for Nonradiographic Axial Spondyloarthritis
https://www.medscape.com/viewarticle/931543

May 31st, 2020 - The Food and Drug Administration has extended approval of ixekizumab (Taltz) to the treatment of nonradiographic axial spondyloarthritis (nr-axSpA), according to a press release from its manufacturer, Eli Lilly. Specifically, this supplemental bio...

Long-Term Use of Biologics Does Not Appear to Raise Melanoma Risk
https://www.medscape.com/viewarticle/931244

May 28th, 2020 - NEW YORK (Reuters Health) - Patients treated with biologic therapy for rheumatoid arthritis, inflammatory bowel disease, and psoriasis don't appear to be at increased risk of melanoma, according to the results of a systematic review and meta-analy...

Fast Five Quiz: Systemic Treatments for Plaque Psoriasis
https://www.medscape.com/viewarticle/929577

May 20th, 2020 - Approximately 125 million people around the world are affected by psoriasis, a chronic, relapsing inflammatory skin disorder. Several clinical variants of psoriasis are recognized, but plaque psoriasis is the most common. Psoriasis is associated w...

Fast Five Quiz: Plaque Psoriasis Presentation and Diagnosis
https://www.medscape.com/viewarticle/929579

May 20th, 2020 - Plaque psoriasis is a chronic inflammatory disease that primarily affects the skin and joints. Globally, approximately 125 million people have psoriasis. Certain medications, infections, skin trauma, obesity, and stress have been recognized as dis...

Psoriasis Independently Linked to Risk of Serious Infection
https://www.medscape.com/viewarticle/928256

Apr 5th, 2020 - Takeaway Psoriasis was independently associated with a small but increased risk of serious infection. People with psoriasis had an increased risk of hospitalisation because of any infection; respiratory infections; soft tissue and skin infections....

see more →

Patient Education  213 results see all →